Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil

scientific article published on 01 November 1998

Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1368-8375(98)00068-2
P698PubMed publication ID9930359

P2093author name stringG M McCarthy
M Vincent
W I Kocha
H Ghandi
J D Awde
P2860cites workOrofacial complications of chemotherapy for breast cancerQ28326692
Toxicity and response criteria of the Eastern Cooperative Oncology GroupQ29619399
Reporting results of cancer treatmentQ29620070
Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trialQ33377409
An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer.Q33391080
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerQ33488159
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancerQ33492422
Radiation-induced xerostomia in cancer patients.Effect on salivary and serum electrolytesQ39102622
Treatment of radiation- and chemotherapy-induced stomatitisQ39518299
Fluorouracil: biochemistry and pharmacologyQ39527807
Xerostomia: Diagnosis and treatmentQ40159396
Oral complications in patients receiving treatment for malignancies other than of the head and neckQ40557148
Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapyQ40716256
Periodontal infection in patients with acute nonlymphocyte leukemia. Prevalence of acute exacerbationsQ40846087
Physiological aspects of aging. Implications for the treatment of cancerQ40931106
Studies of oral neutrophil levels in patients receiving G‐CSF after autologous marrow transplantationQ41079186
A comparative study of herpes simplex infections in renal transplant and leukemic patientsQ42058885
Cancer statistics, 1995.Q43686273
Oral mucosal status and major salivary gland function.Q44922190
A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemiaQ45831016
Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetateQ48906248
The Functions of SalivaQ55892987
Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancerQ61917339
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapyQ67482465
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinomaQ67549025
Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunctionQ67960755
Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trialQ68497740
Neutropenic ulceration. A distinctive clinical entityQ68749435
Clinical characteristics and mechanisms involved in chemotherapy-induced oral ulcerationQ68758707
Variables predicting oral mucosal lesions in allogenic bone marrow recipientsQ70163687
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancerQ70670951
Chemotherapy-induced oral mucositis in adult leukemiaQ71450733
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experienceQ71613641
Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositisQ71705617
Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidantsQ72120609
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaQ72520138
Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapyQ72657060
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neckQ72680240
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialQ72732640
Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitisQ72780566
P433issue6
P921main subjectfluorouracilQ238512
P304page(s)484-490
P577publication date1998-11-01
P1433published inOral OncologyQ7099367
P1476titleRisk factors associated with mucositis in cancer patients receiving 5-fluorouracil
P478volume34

Reverse relations

cites work (P2860)
Q52560942A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.
Q43844206A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy
Q40254265A survey of National Cancer Institute-designated comprehensive cancer centers' oral health supportive care practices and resources in the USA.
Q34403510Adverse event management of oral mucositis in patients with breast cancer
Q35867296Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa
Q57065023Anthocyanins Extracted from L. Prevent Fluorouracil-Induced Nuclear Factor-κB Activation in Oral Mucositis: In Vitro and In Vivo Studies
Q40741211Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats
Q46059347Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2.
Q34087232Chemotherapy-induced oral mucositis. Prevention and management
Q35219131Drug effects on salivary glands: dry mouth
Q55709896Elemental Diet Accelerates the Recovery From Oral Mucositis and Dermatitis Induced by 5-Fluorouracil Through the Induction of Fibroblast Growth Factor 2.
Q36458432Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy
Q33874148Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis
Q38833088Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon
Q87423296Low body mass index as a risk factor of moderate to severe oral mucositis in oral cancer patients with radiotherapy
Q36494114Management of oral mucositis in patients who have cancer
Q92941250Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
Q34317762Mucositis and salivary antioxidants in patients undergoing bone marrow transplantation (BMT)
Q64100060Oral Health Status and Oral Health-related Quality of Life According to Presence or Absence of Mucositis in Head and Neck Cancer Patients
Q33195001Oral and intestinal mucositis — causes and possible treatments
Q46539342Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients
Q51503216Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors.
Q37554896Prevention and management of adverse events related to regorafenib
Q37454779Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study
Q79611039Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats
Q84349532Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy
Q36965711Radiation therapy and chemotherapy-induced oral mucositis
Q45254400Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation
Q34070317Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer
Q33260759Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy
Q35037721Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions
Q40337532The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies.